GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fukuda Denshi Co Ltd (TSE:6960) » Definitions » ROE %

Fukuda Denshi Co (TSE:6960) ROE % : 8.88% (As of Dec. 2023)


View and export this data going back to 1982. Start your Free Trial

What is Fukuda Denshi Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Fukuda Denshi Co's annualized net income for the quarter that ended in Dec. 2023 was 円15,304 Mil. Fukuda Denshi Co's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was 円172,353 Mil. Therefore, Fukuda Denshi Co's annualized ROE % for the quarter that ended in Dec. 2023 was 8.88%.

The historical rank and industry rank for Fukuda Denshi Co's ROE % or its related term are showing as below:

TSE:6960' s ROE % Range Over the Past 10 Years
Min: 7.8   Med: 8.52   Max: 11.65
Current: 11.65

During the past 13 years, Fukuda Denshi Co's highest ROE % was 11.65%. The lowest was 7.80%. And the median was 8.52%.

TSE:6960's ROE % is ranked better than
80.12% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 0.25 vs TSE:6960: 11.65

Fukuda Denshi Co ROE % Historical Data

The historical data trend for Fukuda Denshi Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fukuda Denshi Co ROE % Chart

Fukuda Denshi Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.24 7.89 11.22 11.27 11.04

Fukuda Denshi Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.95 14.20 8.54 15.05 8.88

Competitive Comparison of Fukuda Denshi Co's ROE %

For the Medical Devices subindustry, Fukuda Denshi Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fukuda Denshi Co's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's ROE % distribution charts can be found below:

* The bar in red indicates where Fukuda Denshi Co's ROE % falls into.



Fukuda Denshi Co ROE % Calculation

Fukuda Denshi Co's annualized ROE % for the fiscal year that ended in Mar. 2023 is calculated as

ROE %=Net Income (A: Mar. 2023 )/( (Total Stockholders Equity (A: Mar. 2022 )+Total Stockholders Equity (A: Mar. 2023 ))/ count )
=17278/( (149856+163047)/ 2 )
=17278/156451.5
=11.04 %

Fukuda Denshi Co's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=15304/( (171474+173231)/ 2 )
=15304/172352.5
=8.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Fukuda Denshi Co  (TSE:6960) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=15304/172352.5
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(15304 / 130868)*(130868 / 210767.5)*(210767.5 / 172352.5)
=Net Margin %*Asset Turnover*Equity Multiplier
=11.69 %*0.6209*1.2229
=ROA %*Equity Multiplier
=7.26 %*1.2229
=8.88 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=15304/172352.5
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (15304 / 21916) * (21916 / 21340) * (21340 / 130868) * (130868 / 210767.5) * (210767.5 / 172352.5)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.6983 * 1.027 * 16.31 % * 0.6209 * 1.2229
=8.88 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Fukuda Denshi Co ROE % Related Terms

Thank you for viewing the detailed overview of Fukuda Denshi Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fukuda Denshi Co (TSE:6960) Business Description

Traded in Other Exchanges
N/A
Address
39-4, Hongo 3-chome, Bunkyo-ku, Tokyo, JPN, 113-8483
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.

Fukuda Denshi Co (TSE:6960) Headlines

No Headlines